Clinical Trial Update: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate [Phase 3]

View source ↗

Summary

Phase 3 randomized trial update (RE-LY) evaluating long-term anticoagulation with dabigatran etexilate for atrial fibrillation and stroke; trial completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: COMPLETED | Results posted: 2011-02-10